Some Thoughts on the Management of Technology with Special Reference to N. gonorrhoeae and Penicillin  (Preliminary Draft) by Federer, W. T. et al.
BU-445-M 
Some Thoughts on the ;.Ianagement of Technology 




w. T. Federer 
ABSTRACT 
January, 19'{3 
A number of experiments are proposed ~o obtain factual data on the effect 
cf relaxed selection pressure on the build-up of resistance of bacterial disease 
organisms to antibiotics. One possible scheme for retaining a level of suscepti-
bility in a population of disease organisms is set forth. Similar procedure could 
be utilized with pesticides. 
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1. INTRODUCTION 
January, 1973 
The first seventy-two years of the twentieth century have been associated with 
fantastic advances in technology from the horseless carriage and Model T Ford to the 
routine Apollo missions to the moon. There is no question but that the development 
of new technology has been most rapid, but there is also no question that some of 
these developments have been misused ~r mismanaged with sometimes serious consequences. 
Pollution by chemicals, by human wastes, by noise, by discarded or obsolete appliances, 
by overpopulation, of the mind, of the body, of the water, of the air, etc. is in 
evidence eve~.,here. The side--effects of technology, whether it be electronic or 
medical, are becoming evident. It is also becoming evident that the physical and 
biological scientists have been doing an excellent job at innovation but that the 
legal, political, and social scholars have fallen flat on their faces in presenting 
ways for man to adjust and t0 live with the rapid advance of technology. Should the 
physical and biological scientists address themselves to this problem? It appears 
that they will have to if man is to avoid a serious, or perhaps even fatal, catas-
trophe. 
It would appear that it will be necessary for the physical and biological sci-
entists to address themselves to the management (use) of the technology developed to 
date. New technology will continue to be developed since it is almost impossible to 
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eliminate man's innovative and creative nature even under the most dictatorial of 
political regimes. This characteristic has allowed him to survive and to evolve 
through the years, and, barring a fatal catastrophe, it will enable him to survive 
in the future and to use technology without serious side effects. In order to accom-
plish this, the physical and biological scientists will need to divert a sizeable 
portion of their energies in this direction in the next fevr years. 
The developers of new technology have been content to let others study and re-
port on side-effects and spin-offs of the new development. They have tended to let 
the legislative and executive branches of a government and their regulatory agencies 
worry about side effects. These have failed and are failing in many areas as evi-
denced by some of our present problems, with one reason for these failures being the 
very rapid advances in technology. By the time a problem is resolved, it is no longer 
needed because a new product has been developed in the interim. Hence, it may be 
necessary to delay the applications and uses of technology until a thorough study 
has been made of side effects. 
2. A SPECIFIC PROBLEM 
As many of you may know, the disease knovm as gonorrhea is in epidemic propor-
tions at the current time. It is estimated that 50% of all high school students in 
1980 will have or will have had the disease. However, as statisticians should know, 
extrapolation can be highly inaccurate. Despite this, gonorrhea is a serious disease, 
and it may become even more serious during the next decade unless steps are taken to 
control the disease. We know that the spread of the disease is through contact with 
sexual organs in both heterosexual and homosexual contacts. The rate of infection 
from sexual intercourse with no precautions is of the order of 5o%, depending upon 
the strain of the bacteria N. gonorrhoeae. There are numerous strains as Bristol 
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Laboratories has over 250 isolates in their possession. The strains or isolates ex·· 
hibit different reactions to specified dosages of an antibiotic. One incident re-
ported was that of a girl who took a six-weeks trip on the Eastern Coast of the U.S. 
During this period she had sexual intercourse with 163 different men. Eighty-one of 
the 163 contracted the disease gonorrhea from her. If the sexual parts are washed 
with soap and water both before and after intercourse, the rate of infection for 
some strains can be reduced to ten per cent or less. 
The detection of the disease can often be made through external symptoms on the 
sexual organs and/or through blood tests. However, for certain strains, the female 
may be a carrier of the disease and have no external symptoms. A new strain has re-· 
cently been reported which exhibits no symptoms in the male but does in the female. 
To my knowledge, blood tests by trained medical observers will detect the presence 
or absence of the disease in nearly all cases, even if no symptoms are present in 
the carrier of the disease organism. 
The medical treatment for this disease can take many forms such as the use of 
soap and water, abstinence both voluntarily and nonvoluntarily (for example, through 
isolation of the sexes or through the use of Big Brother's chastity belt), by the 
use of a mercury treatment which was in vogue before the advent of antibiotics, 
penicillin, and other antibiotics. One of the big questions now is the licensing 
of other antibiotics to treat the disease; another problem is to develop new medical 
treatments, perhaps for specific strains of!'!· gonorrhoeae. This problem is accom-
panied by the need for methods for the rapid identification of strains of the bac-
terium involved in a particular diseased patient. 
The problems associated with the moral, social, and legal aspects of the disease 
are not even formulated, let alone being resolved. For example, a boy contracted 
gonorrhea from his 11 steady" girl friend. It was discovered that this "steady'1 girl 
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friend had. also infected thirteen other boys at the College. In a second example, 
two members of a commune in l1ichigan killed a girl because she had infected one of 
them with gonorrhea. These examples illustrate the fact that there are moral, social, 
and legal problems involved when one person transmits a disease to another. Of 
course, our present social and moral codes prohibit one person from bringing damage 
suits against the person from whom the disease gonorrhea was contracted, but the 
present course of events also indicate that this may be a real possibility in the 
1980's or 1990's. This would appear to be an area in which the social scientists, 
political scientists, and legal experts should become active. Scholarly work should 
be done prior to legislation being enacted. The "right" to "do your thing" without 
considering the effect on others may become a thing of the past. 
3· THE LICENSING OF DRUGS 
A new antibiotic must possess no "significant correlation" with penicillin in 
the reactions of n isolates of~· gonorrhoeae to the two drugs. This criterion is 
used because "the ability of ~· gonorrhoeae isolates to develop resistance to multi-
ple antibiotics is very troublesome". A relatively large number of randomly selected 
isolates, as well as a large number of known antibiotic resistant isolates, must be 
studied prior to reaching conclusions about the correlation between the reactions of 
isolates to the two drugs. Many gonococcal strains are required before it is con-
sidered possible to make a comparison of cross-antibiotic resistance of two antibi-
otics. 
From a statistician's view of the preceding paragraph describing the procedure, 
it would appear that the null hypotheses of zero-correlation between the two drugs 
was being considered for licensing a new drug. We shall show in the next sections 
that this is a nonsensical procedure if it means that new drugs cannot be licensed 
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for treating gonorrhea. Furthermore, what is large, what is significant, and what 
is many? A statistician or anyone else is unable to work vrith such vague terms and 
imprecise definitions. 
4. THE REAL PROBLEM OF TREATMENT 
The real goal of any health program on the disease gonorrhea should be to keep 
the incidence of the disease low (which needs to be defined) and to keep the popula-
tion of gonococcal strains ~ susceptible ~ practically possible to treatment with 
antibiotics. We know that a population composed mainly of individuals from strains 
which are resistant to allowable dosages of an antibiotic means that the antibiotic 
is useless in the treatment of the disease. This could easily become the case with 
penicillin. The build-·up of resistant strains in the population of !!· gonorrhoeae 
could render this excellent antibiotic useless. The build-up of resistance is a 
real possibility due to what I consider to be a serious misuse and mismanagement of 
the use of all antibiotics. The indiscriminant use of antibiotics in animal foods 
and by the medical profession for any infection, including the common cold, hastens 
the development of a population of resistant strains of the bacteria. Thus, we must 
devise ways to manage the use of antibiotics unless they are to be rendered useless 
through malpractice. A wonderful development in technology such as that related to 
antibiotics can easily be rendered unusable by industry and medical profession mis-
managements. As we shall see later, the problem is even more complicated than indi-
cated above. 
With regard to the validity of the null hypothesis of zero cross correlation 
bet'\veen reactions of strains of ~· gonorrhoeae to different dosages of two drugs, we 
know from gen~c breeding theory and practic~ that it is possible to locate strains 
which are both resistant or both susceptible to treatment by two antibiotics. Hence, 
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the null hypothesis is false and finding significance is merely a matter of having 
a large enough sample size. Therefore, the present criterion on a unonsignificant 
cross-correlationu which is utilized in determining whether or not a new antibiotic 
is licensed and which is described in the preceding section, is nonsensical on both 
biological and statistical grounds. uNonsignificant correlations" will then be a 
matter of sampling variation in a population wherein the null hypothesis does not 
hold. 
There is also the possib~:ity that changes occur in the model of resistance to 
an organism. In stem rust infections of wheat, one theory is that if there are major 
genes for resistance in the wheat strains being grown, the organism develops a re-
sistance to these major genes and continues to survive. If now only wheat strains 
are grown which do not carry these resistant genes, the frequency of the resistant 
genes in the rust organisms tends to decrease, perhaps because they have a lower 
reproductive and lower survival rate. It may be that the mode of resistance of wheat 
varieties to rust is changed rather than this being a loss of resistance. There is 
some work by Van der Plank and in Australia on these ideas associated with the 
simultaneous build-up of resistance in both wheat and in the rust organism with one 
type of resistance counteracting the other. 
About 1958 a Japanese researcher reported that organisms of one bacterial 
species could transfer a chunk of RNA to organisms of a second species, making them 
resistant to treatment with antibiotics. This is called a "resistance factor". 
Hence, organisms such as !· coli which inhabit the intestinal region of man are 
capable of transferring the resistance factor to other bacteria which cause bacterial 
diseases, such as gonorrhoea and spinal meningitis. The "resistance factor" makes 
the organisms resistant to all antibiotics. Thus, the build-up of a population of 
crganisms carrying the "resistance factor 11 could render antibiotics useless for the 
treatment of all bacterial diseases. Hence, a goal should be to keep the frequency 
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of the tlresistance factortl in the population as lovr as possible. It is also known 
that the reproduction and survival rate of organisms carrying the extra piece of RNA 
is lower than for other organisms, and this fact could be utilized in a drug manage-
ment program. 
The picture relative to the use of antibiotics appears pretty dismal if present 
antibiotic practices by the animals foods industries and the medical profession are 
continued. Also, the practice by regulatory agencies of limiting the licensing of 
antibiotics for the treatment of gonorrhea will lead to the untenable situation that 
antibiotics will be relatively useless for the treatment of the disease. This would 
mean a return to previous treatments for treating the disease or the development of 
a new treatment through an advance in technology. 
5. SOlviE QUESTIONS AND PROPOSALS 
Urgently needed for biological and medical theory is the answer to the following 
questions: 
(i) After a build-up of a specified level of resistance in a population of organ-
isms due to continued selection pressure, how many generations does it require for 
the level of resistance to return to its original state if the selection pressure is 
removed? 
(ii) Is the return to the original state dependent upon the level of resistance 
developed? 
(iii) How long and under vrhat kind of selection pressure does it take to attain a 
specified level of resistance? 
(iv) Do the answers to the above questions vary with species and with strains within 
species? 
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(v) What types of back--selection pressure may be useful in returning to the origi-
nal state of resistance? 
(vi) Are there selection regimes which would lower the frequency of resistant strains 
in a population while at the same time reducing the incidence of the disease? 
(vii) What are the roles of linkage, inversions, translocations, mutations, and of 
the transfer of genetic material between individuals both within and between species 
(e.g. the "resistance factor")? 
(viii) What published information is really available to answer these questions and 
where is research being initiated to obtain answers to the above questions? 
(ix) Should biological scientists continue their current studies in which they have 
vested interests or should they obtain answers to questions related to the management 
of technology? 
(x) What are the roles of the biologist and of the biometrician in this research? 
From conversing with a number of biologists it would appear that there is very 
little in the way of published literature or answers to the above questions. There 
is the work by Alan Robertson on back selection; also, there are results by K. E. 
Papa on selection in Neurospora and by D. Pimentel on selection studies in the house 
fly, and the results by Van der Plank mentioned previously. These are insufficient 
to provide answers to the above questions. It would appear that a large research 
effort will be required to obtain the desired answers necessary to implement some of 
the following proposals. 
Suppose that the generation or selection interval is known for gonorrhea, for 
example, say a three-month period. Also, suppose that one knows that the level of 
resistance built up in a selection period of three months is diminished to its origi-
nal level if selection pressure is eliminated for nine selection periods (27 months). 
.. . " 
-9-· 
Then, one management scheme f'c)r the use of ten antibiotics and/ or other treatments 
for the disease would be to divide North America up into ten areas. The prevalent 
treatment in one of the ten areas would be determined by its location in a 10 X 10 
latin square arrangement 1·rhere the columns vrould be the ten areas, the rows would be 
the ten time periods, and the ten treatments would be the ten medical treatments. 
Any patient not respcnding to one medical treatment would be treated with other treat-
ments until he was cured. Starting in the eleventh period, the treatments would be 
repeated in the same area that they were in the first period, and the entire process 
would be continued in the 12th to the 20th periods. Thus, if the resistance of the 
population could be kept at the original level by this management scheme, the ten 
medical treatments would retain their effectiveness in treating the disease and in 
loVJering its incidence rate. 
i.VIany experiments need to be conducted Hith laboratory organisms. Perhaps the 
VTOrk should first be done on E. coli or some other laboratory organism prior to ex-
perimenting directly Hith gonococcal strains. However, the two plans below use N. 
gonorrhoeae to illustrate the procedure. 
Plan for experiment_l:_ 
?tep 0: Obtain isolates from ten (or more) randomly selected strains from the 25( 
or more strains of N. gonorrhoeae to form ten populations. 
Step 1: Treat a subpopulation from each population with .1 units/ml of penicillin 
for g generations. 
Step 2: Treat a second subpopulation from each of the ten populations with .2 units'ml 
of penicillin for g generations. 
Steps: Treat the sth subpopulaticn frcm each of the ten populations with s(.l' 
units/ml of penicillin for g generations. 
At the end of each step place one-half of the population in an environment with no 
, . -
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penicillin for ns many ::;enerations as are necessary tu bring the population to its 
original level of resistance. At all steps and all generations for each population, 
measure the amount of resistance present to penicillin. 
Plan for experiment 2: 
Obtain a random selection of isolates from a number of strains (say 15). !\.fake 
up 15 populations for each of the 15 strains and a 16th population which is a com-
posite of the 15. Use a number of antibiotics (say 10) and use a number of levels 
of dosages (say 3) for each antibiotic. For each dosage level treat each of the 16 
populations for a number of generations (say 4) for a specified period of time (say 
3 months), then switch to a second antibiotic at the same dosage level for the second 
period of time for each population; continue this until all ten treatments have been 
used on each antibiotic. At the end of each period measure the level of resistance 
present before proceeding to apply the next treatment. The goal here would be to 
obtain some evidence for the number of generations and the length and number of the 
periods required to keep the resistance of a population to a particular drug at a 
constant level. 
Data from experiments of this nature woulc provide some answers to the questions 
raised at the beginning of this secticn and to the problem of a sensible program for 
using antibiotics to treat gonorrhea. 
Similar experiments should be utilized to study management schemes for pesti-
cides and fungicides. DDT was a vTOnderful inv<:ction but it::; misuse has led .to a ban 
on the use of the advance in technology. 
<- • • l 
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